Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS).

西班牙肉瘤研究小组 （ GEIS ） 对腹膜后肉瘤患者诊断和治疗的最新审查和临床建议。

• 影响指数: 6.575
• 发表时间: 2023 Jun 15
• 来源期刊: Cancers (Basel)
• DOI: 10.3390/cancers15123194
• PMID: 37370803
• 文章类型: Journal Article
• 中科院分区: Q2
• 方向: 医学
• 作者列表: Álvarez Álvarez R,Manzano A,Agra Pujol C,Artigas Raventós V,Correa R,Cruz Jurado J,Fernandez JA,Garcia Del Muro X,Gonzalez JA,Hindi N,Lozano Lominchar P,Martínez-Trufero J,Méndez R,Muñoz M,Muñoz Casares C,Orbis Castellanos F,Orellana Fernandez R,Paniagua González M,Redondo A,Valverde Morales C,Asencio JM

关键词: multidisciplinary board; reference centers; retroperitoneal sarcoma; retroperitoneum; soft tissue sarcoma

Abstract

Soft tissue sarcomas (STS) are an uncommon and biologically heterogeneous group of tumors arising from mesenchymal cells. The incidence is estimated at five cases per 100,000 people per year. Retroperitoneal sarcomas (RPS) account for 10-15% of all STS, and their management depends on their anatomical characteristics and histotype. Due to their very low incidence, it is recommended that RPS be treated in reference centers and evaluated by an experienced multidisciplinary team (MDT). In Spain, the Spanish Group for Research in Sarcomas (GEIS) brings together experts from various specialties to promote research on sarcomas and improve treatment results. This paper summarizes the GEIS recommendations for the diagnosis, treatment, and follow-up of patients with RPS.

摘要

软组织肉瘤（STS）是由间充质细胞引起的罕见且生物学异质性的肿瘤。发病率估计为每年每100,000人中有5例。腹膜后肉瘤（RPS）占所有STS的10-15％，它们的管理取决于它们的解剖特征和组织型。由于其发病率非常低，建议在参考中心治疗RPS,并由经验丰富的多学科团队(MDT)进行评估.在西班牙,西班牙肉瘤研究小组（GEIS）汇集了来自各个专业的专家，以促进肉瘤的研究并改善治疗结果。本文总结了GEIS的诊断建议，治疗,并对RPS患者进行随访。